FDA Drug Application (090602) for NIFEDIPINE by MATRIX LABS LTD

Back to FDA Applications sponsored by MATRIX LABS LTD

Application Number090602
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNIFEDIPINE
Active IngredientNIFEDIPINE



Back to FDA Applications sponsored by MATRIX LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.